Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H2 2022

European Healthtech startup funding raised during H2 2022.

In H2 2022, 308 European Healthtech companies closed 327 funding rounds and raised €3.5B in equity funding (excluding debt and grants), down 39.7% versus H2 2021. Debt rounds added €624M. UK led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.

Equity funding
€3.5B
-39.7% vs H2 2021 · excl. debt & grants · +€624M debt
Funding rounds
327
-13.0% vs H2 2021
Companies
308
Top country
UK
Rank among sectors
#4
9.4% of sector funding
Debt financing
€624M
15.1% of total
Top-10 round share
32.4%
of disclosed capital
Rounds ≥ €100M
8

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H2 2022 — interactive chart.
Data table
FundingRounds
Jul€927M52
Aug€701M42
Sep€523M51
Oct€726M66
Nov€729M62
Dec€526M54

Top countries

by € raised
Healthtech — top countries by capital, H2 2022 — interactive chart.
Data table
Healthtech — top countries by capital, H2 2022
UK€1.2B
Germany€684M
Switzerland€628M
Sweden€281M
France€272M
Denmark€218M
Belgium€215M
Spain€156M

Stage mix

by € raised
Healthtech — stage mix, H2 2022 — interactive chart.
Data table
Healthtech — stage mix, H2 2022
Other€1.7B
Series A€747M
Debt€624M
Series B€519M
Seed€212M
Series D+€146M
Series C€137M
Grant€45M
Pre-Seed€18M
Growth/Late€16M
Crowdfunding€3.0M
Early VC€2.5M

Exits & M&A

38 Acquisition · 1 IPO

39 exits · €5.1B disclosed.

ImmucorAcquisitionNov 2022€2.0B
TeneoTwoAcquisitionJul 2022€1.2B
MiroBioAcquisitionAug 2022€396M
Neogene TherapeuticsAcquisitionNov 2022€310M
MiranzaAcquisitionSep 2022€250M
CordisAcquisitionOct 2022€240M

Top deals

largest disclosed rounds in H2 2022
CompanyStageDateAmount
CompuGroup MedicalDebtJul 2022€200M
CeraOtherAug 2022€157M
CeraDebtAug 2022€157M
KryOtherJul 2022€157M
VectivbioOtherOct 2022€127M
NovaremedOtherJul 2022€127M
TauRx PharmaceuticalsOtherNov 2022€115M
Demant ASDebtNov 2022€115M
KerecisSeries D+Jul 2022€99M
Osler DiagnosticsSeries CNov 2022€85M
SparingvisionSeries BSep 2022€75M
Resolve BiosciencesSeries BOct 2022€72M
Pheon TherapeuticsSeries ASep 2022€71M
F2GOtherAug 2022€69M
ReplaySeedJul 2022€54M

Top investors

most active in H2 2022, by deal count